Numinus Says FDA Decision on New Therapy "A Blow", But Adds It Is Not Dependent On New Therapies; Also Terminated LoI With MedBright AI
Numinus Says FDA Decision on New Therapy "A Blow", But Adds It Is Not Dependent On New Therapies; Also Terminated LoI With MedBright AI
Numinus表示FDA對新療法的決定是一個打擊，但補充說不依賴新療法；此外已經終止與MedBright AI的意向書。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊